Ignite Creation Date:
2024-05-05 @ 11:14 PM
Last Modification Date:
2024-10-26 @ 10:30 AM
Study NCT ID:
NCT01282476
Status:
TERMINATED
Last Update Posted:
2017-05-09
First Post:
2011-01-21
Brief Title:
Panobinostat With Rituximab for RelapsedRefractory Diffuse Large B Cell Lymphoma
Sponsor:
Massachusetts General Hospital
Organization:
Massachusetts General Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Diffuse Large B Cell Lymphoma |